Tag:
Health
Health
Neuraptive Therapeutics, Inc. Announces Achievement of Proof of Concept in The NEUROFUSE Study of NTX-001 for the Adjunct Treatment of Transected Peripheral Nerves
Business Wire India
The NEUROFUSE Study is an ongoing 48-week Multicenter, Randomized, evaluator-blinded, Phase 2a study in upper extremity nerve transections comparing NTX-001 adjunctive...
Health
Hearing loss heightens dementia risk, study reveals
Individuals with hearing loss face a heightened risk, up to 13%, of developing dementia compared to those with normal hearing.
Researchers from the Department of...
Health
Aptia, Leading New Pensions and Employee Health and Benefits Specialist, Formally Launches with 1,100 Clients and Supporting 7 Million People
Business Wire India
Aptia (the “Company”), a dedicated pension, health and benefits administration specialist, today announced its formal launch with 1,100 global clients to support...
Economy
ENYO Pharma Announces a €39 Million Series C Financing and FDA Clearance to Advance Vonafexor in a Phase 2 Clinical Trial for Patients With...
Business Wire India
The Company will initiate a Phase 2 clinical study of Vonafexor in Alport Syndrome - called “ALPESTRIA-1” - in the first...
Health
Dr. Jitendra Singh urges collective action in the fight against diabetes
In a recent address during the launch of the Rural Diabetes Prevention & Control Campaign in Varanasi, Union Minister Dr Jitendra Singh expressed deep...
Health
Fujirebio Expands Its Alzheimer’s Disease Test Menu With the Much Awaited and Fully Automated Lumipulse® G pTau 217 Plasma Assay for Research Use Only...
Business Wire India
H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 Plasma assay for...
Health
Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates Targeting Solid Tumors
Business Wire India
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotech company focusing on the discovery and development of novel antibody therapeutics,...
Health
Terumo India Advances Treatment Options for Heart Disease with the Launch of Ultimaster Nagomi
Business Wire India
Terumo India, the Indian arm of Japan based Terumo Corporation (TSE: 4543), a global leader in medical technology, recently announced the launch...